Oncology Medical News about Salivary Glands Thyroid Neoplasms Amifostine Amifostine

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Amifostine for salivary glands in high-dose radioactive iodine treated differentiated thyroid cancer
Cochrane Reviews, 10/09/09

Ma C et al. – Amifostine is thought to be a radioprotector of salivary glands used in conjunction with radioiodine therapy. This medication is administered intravenously and was reported to ameliorate the damage of salivary glands caused by radioactive iodine therapy...The authors found only two randomised controlled trials in which the effects of amifostine were compared with placebo. Results from two randomised controlled clinical trials suggest that the amifostine has no significant radioprotective effects on salivary glands in high–dose radioactive iodine treated differentiated thyroid cancer patients. Moreover, no health–related quality of life and other patient–oriented outcomes were evaluated in the two included trials. Randomised controlled clinical trials with low risk of bias investigating patient–oriented outcomes are needed to guide treatment choice.

<< Previous
Adjuvant radiotherapy and chemoradiation after surgery for...

Next >>
Selective internal radiation therapy for liver metastases from...

Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: Report of a case
Surgery Today, 10/06/09 Relevance Score: 81%

Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior
BMC Cancer, 11/13/09 Relevance Score: 80%

Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
European Journal of Endocrinology, 10/06/09 Relevance Score: 79%

Development and application of magnetic resonance elastography of the normal and pathological thyroid gland in vivo
Journal of Magnetic Resonance Imaging, 11/09/09 Relevance Score: 68%

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09 Relevance Score: 68%